These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3085911)

  • 41. Pituitary disorders and pregnancy.
    Nader S
    Semin Perinatol; 1990 Feb; 14(1):24-33. PubMed ID: 2180073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Medical therapy of hyperprolactinemia.
    Dalkin AC; Marshall JC
    Endocrinol Metab Clin North Am; 1989 Jun; 18(2):259-76. PubMed ID: 2663475
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical and therapeutic particularities of depression associated with pituitary adenoma].
    Ghanem A; Mouna A; Ben Nasr S; Ben Hadj AB
    Tunis Med; 2009 Aug; 87(8):547-8. PubMed ID: 20180366
    [No Abstract]   [Full Text] [Related]  

  • 44. Is pregnancy the best treatment for hyperprolactinaemia?
    Crosignani PG; Mattei AM; Scarduelli C; Cavioni V; Boracchi P
    Hum Reprod; 1989 Nov; 4(8):910-2. PubMed ID: 2575622
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Continuous bromocriptine treatment of empty sella syndrome aggravating pregnancy. A case report.
    Georgiev DB; Dokumov SI
    Gynecol Obstet Invest; 1991; 32(4):243-4. PubMed ID: 1778518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcome and long-term effects of pregnancy in women with hyperprolactinaemia.
    Ampudia X; Puig-Domingo M; Schwarzstein D; Corcoy R; Espinós JJ; Calaf-Alsina J; Webb SM
    Eur J Obstet Gynecol Reprod Biol; 1992 Sep; 46(2-3):101-7. PubMed ID: 1451886
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hyperprolactinemia: importance of early therapy].
    Rachidi-Koussa H; Vergely N; Duthel R; Malluret J; Estour B
    Presse Med; 1994 Nov; 23(36):1669. PubMed ID: 7899295
    [No Abstract]   [Full Text] [Related]  

  • 48. Diagnosis and management of hyperprolactinemia: expert consensus - French Society of Endocrinology.
    Brue T; Delemer B;
    Ann Endocrinol (Paris); 2007 Feb; 68(1):58-64. PubMed ID: 17316545
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinical practice guideline for the diagnosis and treatment of hyperprolactinemia].
    Salazar-López-Ortiz CG; Hernández-Bueno JA; González-Bárcena D; López-Gamboa M; Ortiz-Plata A; Porias-Cuéllar HL; Rembao-Bojórquez JD; Sandoval-Huerta GA; Tapia-Serrano R; Vázquez-Castillo GG; Vital-Reyes VS
    Ginecol Obstet Mex; 2014 Feb; 82(2):123-42. PubMed ID: 24779268
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anesthetic management of 29 week pregnant patient undergoing craniotomy for pituitary macroadenoma--a case report.
    Cok OY; Akin S; Aribogan A; Acil M; Erdogan B; Bagis T
    Middle East J Anaesthesiol; 2010 Feb; 20(4):593-6. PubMed ID: 20394262
    [No Abstract]   [Full Text] [Related]  

  • 51. Follow-up of children born of bromocriptine-treated mothers.
    Raymond JP; Goldstein E; Konopka P; Leleu MF; Merceron RE; Loria Y
    Horm Res; 1985; 22(3):239-46. PubMed ID: 4054844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperprolactinaemia and microadenomas in primary hypothyroidism.
    Thomas DJ; Touzel R; Charlesworth M; Wass JA; Besser GM
    Clin Endocrinol (Oxf); 1987 Sep; 27(3):289-95. PubMed ID: 3427789
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Delivery after bromocriptine therapy.
    Modena G; Portioli I
    Lancet; 1977 Sep; 2(8037):558. PubMed ID: 95756
    [No Abstract]   [Full Text] [Related]  

  • 54. Hyperprolactinaemia increases intraocular pressure in humans.
    Drago F; Cavallaro N; Dal Bello A; Cavaliere S; Spampinato D; Gorgone G
    Metab Pediatr Syst Ophthalmol (1985); 1987; 10(3):76-8. PubMed ID: 3431424
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pregnancy in hyperprolactinemic women.
    Mallmann ES; Nácul A; Spritzer PM
    Acta Obstet Gynecol Scand; 2002 Mar; 81(3):265-7. PubMed ID: 11966486
    [No Abstract]   [Full Text] [Related]  

  • 56. Long-term follow-up of patients with hyperprolactinaemia.
    Jeffcoate WJ; Pound N; Sturrock ND; Lambourne J
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):299-303. PubMed ID: 8949567
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hyperprolactinemia.
    Tritos NA; Klibanski A
    JAMA; 2015 Oct; 314(16):1742-3. PubMed ID: 26505599
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical impact of hyperprolactinaemia.
    Schlechte JA
    Baillieres Clin Endocrinol Metab; 1995 Apr; 9(2):359-66. PubMed ID: 7625989
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Abnormalities of visual evoked responses in hyperprolactinaemia.
    Yeo PT; Kamaldeen S; Walker D
    Clin Exp Neurol; 1988; 25():85-9. PubMed ID: 3267489
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dopaminergic treatments for hyperprolactinaemia.
    Crosignani PG; Ferrari C
    Baillieres Clin Obstet Gynaecol; 1990 Sep; 4(3):441-55. PubMed ID: 1980863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.